Cargando…
Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study
SIMPLE SUMMARY: The prognosis of cervical cancer is significantly influenced by lymph node involvement. The lymphatic system is the primary way of metastasis for cervical carcinoma, and lymph-vascular space invasion (LVSI) is considered the most important risk factor for pelvic lymph node metastasis...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750515/ https://www.ncbi.nlm.nih.gov/pubmed/35008376 http://dx.doi.org/10.3390/cancers14010212 |
_version_ | 1784631478172254208 |
---|---|
author | Tantari, Matteo Bogliolo, Stefano Morotti, Matteo Balaya, Vincent Bouttitie, Florent Buenerd, Annie Magaud, Laurent Lecuru, Fabrice Guani, Benedetta Mathevet, Patrice |
author_facet | Tantari, Matteo Bogliolo, Stefano Morotti, Matteo Balaya, Vincent Bouttitie, Florent Buenerd, Annie Magaud, Laurent Lecuru, Fabrice Guani, Benedetta Mathevet, Patrice |
author_sort | Tantari, Matteo |
collection | PubMed |
description | SIMPLE SUMMARY: The prognosis of cervical cancer is significantly influenced by lymph node involvement. The lymphatic system is the primary way of metastasis for cervical carcinoma, and lymph-vascular space invasion (LVSI) is considered the most important risk factor for pelvic lymph node metastasis (PLNM). Previous studies have not clarified the correlation between lymphangiogenesis and an increased risk of metastasis and tumor recurrence. The evaluation and identification of several markers of lymphangiogenesis may identify patients with high risk of PLNM. Our findings suggest that the lymphatic spread does not required the proliferation of new lymphatic endothelial cells. These results emphasize the importance of pre-existing peritumoral lymphatic vessels in the metastatic process in early cervical cancer. ABSTRACT: Background: In patients with cervical cancer, the presence of tumoral lymph-vascular space invasion (LVSI) is the main risk factor for pelvic lymph node metastasis (PLNM). The objective of this study was to evaluate the presence of several markers of lymphangiogenesis in early-stage cervical cancer and their correlation with PLNM and tumoral recurrence. Materials and Methods: Seventy-five patients with early-stage cervical carcinoma underwent sentinel lymph node (SLN) sampling in association with complete pelvic lymph node dissection. Primary tumors were stained with the following markers: Ki67, D2-40, CD31 and VEGF-C. A 3-year follow-up was performed to evaluate the disease-free survival. Results: Overall, 14 patients (18.6%) had PLNM. Positive LVSI was seen in 29 patients (38.6%). There was a significant correlation between LVSI evidenced by H/E staining and PLNM (p < 0.001). There was no correlation between high Ki67, CD31, D2-40, and VEGF-C staining with PLNM or tumor recurrence. Conclusions: Our data support that lymphatic spread does not require the proliferation of new lymphatic endothelial cells in early-stage cervical cancer. These results emphasize the importance of pre-existing peritumoral lymphatic vessels in the metastatic process in early cervical cancer. None of the markers of lymphangiogenesis and proliferation assessed in this study were predictive of PLNM or recurrence. |
format | Online Article Text |
id | pubmed-8750515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87505152022-01-12 Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study Tantari, Matteo Bogliolo, Stefano Morotti, Matteo Balaya, Vincent Bouttitie, Florent Buenerd, Annie Magaud, Laurent Lecuru, Fabrice Guani, Benedetta Mathevet, Patrice Cancers (Basel) Article SIMPLE SUMMARY: The prognosis of cervical cancer is significantly influenced by lymph node involvement. The lymphatic system is the primary way of metastasis for cervical carcinoma, and lymph-vascular space invasion (LVSI) is considered the most important risk factor for pelvic lymph node metastasis (PLNM). Previous studies have not clarified the correlation between lymphangiogenesis and an increased risk of metastasis and tumor recurrence. The evaluation and identification of several markers of lymphangiogenesis may identify patients with high risk of PLNM. Our findings suggest that the lymphatic spread does not required the proliferation of new lymphatic endothelial cells. These results emphasize the importance of pre-existing peritumoral lymphatic vessels in the metastatic process in early cervical cancer. ABSTRACT: Background: In patients with cervical cancer, the presence of tumoral lymph-vascular space invasion (LVSI) is the main risk factor for pelvic lymph node metastasis (PLNM). The objective of this study was to evaluate the presence of several markers of lymphangiogenesis in early-stage cervical cancer and their correlation with PLNM and tumoral recurrence. Materials and Methods: Seventy-five patients with early-stage cervical carcinoma underwent sentinel lymph node (SLN) sampling in association with complete pelvic lymph node dissection. Primary tumors were stained with the following markers: Ki67, D2-40, CD31 and VEGF-C. A 3-year follow-up was performed to evaluate the disease-free survival. Results: Overall, 14 patients (18.6%) had PLNM. Positive LVSI was seen in 29 patients (38.6%). There was a significant correlation between LVSI evidenced by H/E staining and PLNM (p < 0.001). There was no correlation between high Ki67, CD31, D2-40, and VEGF-C staining with PLNM or tumor recurrence. Conclusions: Our data support that lymphatic spread does not require the proliferation of new lymphatic endothelial cells in early-stage cervical cancer. These results emphasize the importance of pre-existing peritumoral lymphatic vessels in the metastatic process in early cervical cancer. None of the markers of lymphangiogenesis and proliferation assessed in this study were predictive of PLNM or recurrence. MDPI 2022-01-02 /pmc/articles/PMC8750515/ /pubmed/35008376 http://dx.doi.org/10.3390/cancers14010212 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tantari, Matteo Bogliolo, Stefano Morotti, Matteo Balaya, Vincent Bouttitie, Florent Buenerd, Annie Magaud, Laurent Lecuru, Fabrice Guani, Benedetta Mathevet, Patrice Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study |
title | Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study |
title_full | Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study |
title_fullStr | Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study |
title_full_unstemmed | Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study |
title_short | Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study |
title_sort | lymph node involvement in early-stage cervical cancer: is lymphangiogenesis a risk factor? results from the microcol study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750515/ https://www.ncbi.nlm.nih.gov/pubmed/35008376 http://dx.doi.org/10.3390/cancers14010212 |
work_keys_str_mv | AT tantarimatteo lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT bogliolostefano lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT morottimatteo lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT balayavincent lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT bouttitieflorent lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT buenerdannie lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT magaudlaurent lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT lecurufabrice lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT guanibenedetta lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT mathevetpatrice lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy AT lymphnodeinvolvementinearlystagecervicalcancerislymphangiogenesisariskfactorresultsfromthemicrocolstudy |